CervoMed to Participate in the Emerging Growth Conference 66
BOSTON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for...
BOSTON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ: CRVO), a clinical stage company focused on developing treatments for...
Company Also Expects Fourth Quarter 2023 Revenue Above Guidance, Announces General Availability of Augmedix GoSAN FRANCISCO, Jan. 05, 2024 (GLOBE...
Clinical portfolio substantially strengthened through business development in 2023; two phase 3 studies expected to start in 2024Cresemba in-market sales...
Velamoor Expands Role to President and COO; Hammerschmidt to Assume CFO Position Upon Arnold’s RetirementREMOTE-FIRST COMPANY/IRVINE, Calif.--(BUSINESS WIRE)--#NextGenHealthcare--Entering the new...
eClinicalWorks Scribe and healow solutions to assist the specialty center in reducing provider burnout and maximizing savingsWESTBOROUGH, Mass.--(BUSINESS WIRE)--eClinicalWorks®, the...
FRANKLIN, Tenn.--(BUSINESS WIRE)--i2i Population Health’s PRiZiM product has achieved Office of the National Coordinator for Health Information Technology (ONC-Health IT)...
Ontario organization selects cloud-based subscription model of Expanse EHRCANTON, Mass.--(BUSINESS WIRE)--Brant Community Healthcare System (Brantford, ON) is the first MEDITECH...
Mirth® Connect by NextGen Healthcare Adopted by Strategic Reseller PartnersREMOTE-FIRST COMPANY/NEW YORK--(BUSINESS WIRE)--#NextGenHealthcare--NextGen Healthcare, Inc., a leading provider of innovative,...
The healthcare technology leader earned 7 badges in G2's fall report, including Mid-Market and Small Business LeaderBOCA RATON, Fla.--(BUSINESS WIRE)--ModMed®...
Licensed antigens are shared across major subsets of NSCLC and have confirmed presence on the surface of tumor cells, homogeneous...
Presented positive data showing continued durable complete remissions (CR) achieved in 100% of evaluable leukemia patients in Phase 1 investigator-sponsored...
BREAKTHROUGH CLINICAL RESULTS PROVIDE A UNIQUE INSIGHT INTO THE PROGRESSION OF EACH PATIENT'S CANCERCombined DNA Next Generation Sequencing of CTCs...
Leading orthopedic provider adopting athenaOne® for its value as a modern and comprehensive suite of EHR, practice management, and patient...
Agreements Support the Upcoming Launch of VEVYE®NASHVILLE, Tenn.--(BUSINESS WIRE)--$HROW--Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that...
Lion TCR to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to develop and scale TCR-T cell therapies for solid...
Partnership brings together two leaders in next-generation genetic medicines to engineer, co-develop and co-commercialize (50:50 profit share) AAV-delivered CRISPR/Cas-based therapeutics...
Keros commenced a randomized, double-blind, placebo-controlled, two-part Phase 1 clinical trial to evaluate single and multiple ascending doses of KER-065...
Partnership brings together two leaders in next-generation genetic medicines to engineer, co-develop and co-commercialize (50:50 profit share) AAV-delivered CRISPR/Cas-based therapeutics...
NEW YORK, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage...
CHICAGO--(BUSINESS WIRE)--#healthIT--Veradigm Inc. (NASDAQ: MDRX), a leading provider of healthcare data and technology solutions announced today the acquisition of Koha...